Related Experiment Videos
Subacute sclerosing panencephalitis
1Department of Neurology, Brown University, Rhode Island Hospital, Providence, USA.
Abstract:
Subacute sclerosing panencephalitis (SSPE), a neurodegenerative disease caused by a persistent "slow virus infection" with a mutated measles virus, is endemic in much of the developing world. Its incidence will increase in the USA, not only in immigrants, but also because of the 1988-1990 measles epidemic. This report reviews the pathogenesis, clinical and laboratory diagnosis, and future perspectives in treatment and prevention.
Insights
Subacute sclerosing panencephalitis (SSPE) is a severe neurological disease caused by a mutated measles virus. Its incidence is rising in the US due to immigration and past measles outbreaks, necessitating better treatment and prevention strategies.
Area of Science:
- Neurology
- Virology
- Infectious Diseases
Background:
- Subacute sclerosing panencephalitis (SSPE) is a rare, fatal neurodegenerative disease.
- It results from persistent infection with a mutated measles virus.
- SSPE is endemic in developing nations and poses a growing concern in the USA.
Purpose of the Study:
- To review the pathogenesis of SSPE.
- To outline clinical and laboratory diagnostic methods for SSPE.
- To discuss future perspectives for SSPE treatment and prevention.
Main Methods:
- Literature review of SSPE pathogenesis.
- Analysis of clinical and laboratory diagnostic criteria for SSPE.
- Exploration of current and future therapeutic and prophylactic strategies for SSPE.
Main Results:
- Measles virus mutation is central to SSPE pathogenesis.
- Early diagnosis relies on specific clinical and laboratory findings.
- Increased measles incidence in the US may lead to higher SSPE rates.
Conclusions:
- Understanding SSPE pathogenesis is crucial for developing interventions.
- Prompt diagnosis improves patient outcomes.
- Preventive measures, including vaccination, are key to controlling SSPE incidence.